Skip to content
StemRad logo — Radiation Protection on Earth and Beyond

StemRad

Radiation Protection on Earth and Beyond

Founded 2011 Israel Israel 15 employees Series C Total: $6.00M Health Care

General Information

Company Name StemRad
Founded Year 2011
Location Israel Israel
Employees 15
Industries Health Care
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with StemRad. To contact StemRad, visit stemrad.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does StemRad compare?

A PDF of StemRad and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting StemRad soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About StemRad

StemRad, established in 2011 and headquartered in Israel, is a pioneer in developing, manufacturing, and distributing personal protective equipment (PPE) designed for radiation exposure. The company's slogan, "Radiation Protection on Earth and Beyond," underscores its commitment to ensuring safety in high-risk environments. StemRad stands out as the sole producer of PPE specifically engineered to shield against high-energy radiation, employing innovative selective shielding technology. Its clientele spans from first-responders, military personnel, and medical teams to astronauts, offering state-of-the-art solutions tailored to enhance radiation safety without compromising mission objectives. The company boasts a team of radiation biology experts, nuclear physicists, and industrial designers, along with the support of acclaimed scientists, including 3 Nobel Laureates. StemRad's groundbreaking science and meticulous attention to user needs have empowered the wearer with the mobility and comfort necessary to execute critical tasks while remaining protected in the event of radiation exposure. StemRad recently secured a significant $6.00M Series C investment on 03 December 2017, with notable investors such as Jeffrey Vinik and Techstars Ventures demonstrating confidence in the company's cutting-edge technology and its potential to safeguard individuals both on Earth and in outer space. With its unwavering focus on advancing radiation protection, StemRad stands at the forefront of ensuring the safety of our heroes in high-risk environments.

Business keywords: Radiation Protection, Personal Protective Equipment, Radiation Safety, High Energy Radiation, Nuclear Safety, Emergency Response, Space Exploration, Nuclear Reactors, Medical Technology, Gamma Radiation, Acute Radiation Syndrome, Tel Aviv, Israel, First Responders, Nobel Laureates, Industrial Design

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series C $6.00M 2
Jeffrey Vinik, Techstars Ventures
03 Dec 2017

StemRad Alternatives & Competitors

View All Alternatives
StemRad vs

Your trusted source for essential emergency medical supplies, serving EMTs, firefighters, and police...

34 employees
Health Care, Retail
StemRad vs

Zebra Ambulance Solutions streamline urgent patient care by integrating pre-hospital and in-hospital...

Grant
4 employees
Health Care
StemRad vs
BD
BD United States

BD is a global medical technology company that is advancing the world of health™.

46158 employees
Health Care, Manufacturing

FAQ About StemRad

Radiation Protection on Earth and Beyond
StemRad was founded in 2011.
StemRad is headquartered in Israel.
StemRad operates in Health Care. Its work centres on Radiation Protection, Personal Protective Equipment, Radiation Safety and High Energy Radiation.
StemRad has approximately 15 employees.
StemRad has completed 1 funding round, raising a total of $6.00M. The latest funding stage is Series C.
Top alternatives and competitors to StemRad include Med-Tech Resource LLC, Zebra Academy, BD, Zimmer Biomet, coliquio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
StemRad and Med-Tech Resource LLC are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for StemRad, https://bouncewatch.com/company/stemrad, updated 30 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout